Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sitagliptin Tablets USP (25 mg, 50 mg, and 100 mg), a generic version of Januvia Tablets, originally developed by Merck Sharp and Dohme Corp
All prescriptions are issued by licensed physicians in the patient state
Starting BMI People with higher starting BMIs tend to lose more weight in absolute terms, though percentage weight loss is broadly similar across BMI categories in the clinical trials 1,2
January 2026: Mitsubishi Tanabe Pharma enhanced development programs in oral antidiabetic therapies to improve long-term disease management outcomes
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033
The pricing information in this article was accurate at time of publication (January 2026) but may change